Clinical Trial Update: Drug Use Surveillance of Vonoprazan for "Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis"

View source ↗

Summary

A completed clinical trial update for vonoprazan assessing gastric ulcer, duodenal ulcer, and reflux esophagitis with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Gastric Ulcer
• Reflux Esophagitis

Drugs mentioned

• Vonoprazan (vonoprazan)

Snippet

Sponsor: Takeda | Conditions: Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis | Status: COMPLETED | Results posted: 2019-12-12